Medtech companies are slowly beginning to embrace risk in contracts with hospitals. Will AdvaMed embrace the change, go along with it grudgingly or try to fight it?
We are a little more than a month away from the premier medtech executive conference - AdvaMed 2015 in San Diego - where the industry association brings together speakers from across the medtech spectrum to address timely topics.
It also is an occasion for AdvaMed to forward its agenda - what the DC lobby feels is beneficial for the industry as a whole. No surprises there.
For example, last year, in Chicago, the group put forward a report that warned of the consequences of pay-for-performance and risk-based reimbursement models charging that these would lead to blocking off access to potential...